Preoperative serum leptin levels in patients with breast cancer

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 388-391

  Aliustaoglu, Mehmet ^a   Bilici, Ahmet ^b   Gumus, Mahmut ^b   Colak, Aslihan Topal ^b   Baloglu, Gulcan ^b   Irmak, Rahmi ^b   Seker, Mesut ^b   Ustaalioglu, Bala Basak Oven ^b   Salman, Tarik ^b   Sonmez, Berkant ^b   Salepci, Taflan ^b   Yaylaci, Mustafa ^b  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Body mass index; Breast cancer; Leptin; Serum

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LEPTIN; PROGESTERONE RECEPTOR;

ARTICLE; BODY MASS; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; POSTMENOPAUSE; PREMENOPAUSE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SERUM; TUMOR VOLUME; VOLUNTEER;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PREOPERATIVE CARE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77956899107     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9222-z     Document Type: Article

References (27)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32. doi:10.1038/372425a0. (Pubitemid 24365442)
2. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature. 1996;380:677. doi: 10.1038/380677a0. (Pubitemid 26126093)
3. Lindheim SR, Sauer MV, Carmina E, Chang PL, Zimmerman R, Lobo RA. Circulating leptin levels during ovulation induction: relation to adiposity and ovarian morphology. Fertil Steril. 2000;73:493-8. doi:10.1016/S0015-0282(99) 00578-6. (Pubitemid 30109643)
4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyca MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5. doi:10.1056/NEJM199602013340503. (Pubitemid 26033933)
5. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Hegele A, et al. Radioimmunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology. 1996;137: 1501-4. doi:10.1210/en.137.4.1501. (Pubitemid 26098620)
6. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest. 1996;98:1277-82. doi:10.1172/ JCI118913.
7. Konopleva M, Mikhail A, Estrov Z, Zhao S, Harris D, Sanchez- Williams G, et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood. 1999;93:1668-76.
8. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, et al. Biological action of leptin as an angiogenic factor. Science. 1998;281:1683-6. doi: 10.1126/science.281.5383.1683. (Pubitemid 28435586)
9. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-91. doi:10.1038/nrc1408.
10. Ursin G, Longnecker MP, Haile RW, Greenland SA. Metaanalysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 1995;6:137-41. doi:10.1097/00001648- 199503000-00009.
11. Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23: 6365-78. doi:10.1038/sj.onc.1207751. (Pubitemid 39265505)
12. Simons PJ, Annemie MWJ, Schols L, Campfield A, Emiel FMW, Saris WH. Plasma concentration of total leptin and human lungcancer associated cachexia. Clin Sci. 1997;93:273-7.
13. Stattin P, Soderberg S, Hallmans G, Bylund A, Kaaks R, Stenman UH, et al. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab. 2001; 86:1341-5. doi:10.1210/jc.86.3.1341. (Pubitemid 32323026)
14. Neville MC, McFadden TB, Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia. 2002;7:49-66. doi:10.1023/A:1015770423167. (Pubitemid 38420781)
15. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol. 2006;207:12-22. doi:10.1002/jcp.20472.
16. Tessitore L, Vizio B. Leptin: a novel marker for breast cancer progression. In: 2nd Balkan congress on oncology. Izmir; 1998. p. 163-7.
17. Tessitore L, Vizio B, Pesola D, Cecchini F, Mussa A, Argiles JM, et al. Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol. 2004;24:1529-35.
18. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med. 2000;5:421-6.
19. Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol. 2002;21:4467-8.
20. Hou MF, Lin SB, Yuan SS, Tsai SM, Wu SH, Ou-Yang F, et al. The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin Chim Acta. 2003;334:137-44. doi:10.1016/S0009-8981(03)00196-7. (Pubitemid 36836067)
21. Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411:390-5. doi:10.1038/35077256. (Pubitemid 32467050)
22. Willett WC. Fat, energy and breast cancer. J Nutr. 1997;127: 921S-3S.
23. Ozet A, Arpaci F, Yilmaz Ilker M, Ayta H, Ozturk B, Komurcu S, et al. Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol. 2001;31:424-7. doi: 10.1093/jjco/hye097.
24. Mantzoros CS, Bolhke K, Moschos S, Cramer DW. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer. 1999;80:523-6. doi: 10.1002/(SICI)1097-0215(19990209)80:4<523:: AID-IJC7>3.0.CO; 2-C.
25. Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I, et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer. 2006;118: 1414-9. doi:10.1002/ijc.21543.
26. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res. 2004;10:4325-31. doi:10.1158/1078-0432.CCR-03- 0749.
27. Marttunen MB, Andersson S, Hietanen P, Karonen SL, Koistinen HA, Koivisto VA, et al. Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients. Maturitas. 2000;35:175-9. doi:10.1016/S0378-5122(00) 00121-3.